Prosecution Insights
Last updated: November 20, 2026

Andrea Steffel Olson, USPTO Patent Examiner

Listed by the USPTO as OLSON, ANDREA STEFFEL

Tech Center 3700 • Art Units: 1623 1656 1673 1693 3762

This examiner grants 63% of resolved cases

Performance Statistics

62.6%
Allow Rate
-7.4% vs TC avg
1,510
Total Applications
-11.9%
Interview Lift
1153
Avg Prosecution Days
Based on 1434 resolved cases, 2023–2026

Rejection Statute Breakdown

3.1%
§101 Eligibility
17.5%
§102 Novelty
37.5%
§103 Obviousness
22.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18449862 PROCESS FOR THE DE-TRITYLATION OF OLIGONUCLEOTIDES Final Rejection Hoffmann-La Roche Inc.
18714020 METHOD FOR PRODUCING DISACCHARIDE USING BETA-GLUCOSIDASE AND COFACTOR THEREOF AND COMPOSITION FOR INDUCING ENZYME PRODUCTION OF STRAIN OF GENUS TRICHODERMA COMPRISING PRODUCED DISACCHARIDE Non-Final OA CJ CheilJedang Corporation
17904211 LONG CHAIN CARBON AND CYCLIC AMINO ACIDS SUBSTRATES FOR GENETIC CODE REPROGRAMMING Final Rejection THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
18017306 METHOD FOR MODULATING THE BLADDER MICROBIOME TO IMPROVE BLADDER HEALTH Non-Final OA Kimberly-Clark Worldwide, Inc.
18839102 Compounds for Anti-aging Intervention Non-Final OA AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
18713342 FLAVANOID CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF MITOCHONDRIAL DISORDERS Non-Final OA THE CHILDREN'S HOSPITAL OF PHILADELPHIA
18687785 CONJUGATES, COMPOSITIONS, AND METHODS FOR REJUVENATION OF CAR T-CELLS Non-Final OA Purdue Research Foundation
18410094 METHODS OF TREATING HEART FAILURE WITH REDUCED EJECTION FRACTION Non-Final OA ASTRAZENECA AB
18232909 QUINONE METHIDE ANALOG SIGNAL AMPLIFICATION Final Rejection Ventana Medical Systems, Inc.
18646814 APPLICATION OF TYPHANEOSIDE IN PREPARATION OF MEDICINE FOR URIC ACID-LOWERING AND/OR KIDNEY INJURY Non-Final OA Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
18616904 CATALYTIC POLYMERIZATION AND DEPOLYMERIZATION OF 1,6-ANHYDROSUGARS Final Rejection The Trustees of Boston College
18740235 METHODS OF USING COMPOUND OF GLYCOSAMINOGLYCAN Non-Final OA Holy Stone Healthcare Co., Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Andrea Steffel Olson's allowance rate?

62.6% of resolved applications examined by Andrea Steffel Olson were allowed (1,434 resolved cases), compared with 51.0% across Art Unit 1623 over the last five years.

Does an interview help with examiner Andrea Steffel Olson?

This examiner's interview lift is -11.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Andrea Steffel Olson take to allow a patent?

Applications allowed by Andrea Steffel Olson took 1,153 days on average from filing to allowance.

Which art unit does examiner Andrea Steffel Olson work in?

Andrea Steffel Olson examines applications in Art Unit 1623 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month